Professor Aki Tsuchiya
School of Health and Related Research
Co-Director of the Centre for Wellbeing in Public Policy
+44 114 222 3422
Full contact details
School of Health and Related Research
Regent Court (ScHARR)
30 Regent Street
I came to the UK in 1998 as a Visiting Research Fellow at the Centre for Health Economics, University of York, funded as an Overseas Postdoctoral Research Fellow of the Japan Society for the Promotion of Science. I came to Sheffield and joined ScHARR in 2000, where I worked as a Research Associate, a Research Fellow, and a Lecturer. Since 2005, I have held a joint appointment between ScHARR and the Department of Economics, as a Senior Lecturer, a Reader, and a Professor. Currently, I am a co-Director of the Centre for Wellbeing in Public Policy at the University, and a member of the EuroQol Group.
- Research interests
- measuring, valuing, and modelling health, and other aspects of wellbeing
- incorporating equity concerns into social welfare functions
- normative economics of health and beyond
- SIPHER (System-science Informed Public Health and Economic Research for Non-communicable Disease prevention)
- Comparing aversions to outcome inequality and social risk in health and income : an empirical analysis using hypothetical scenarios with losses. Health Economics. View this article in WRRO
- Manipulating the Five Dimensions of the EuroQol Instrument: The Effects on Self-Reporting Actual Health and Valuing Hypothetical Health States. Medical Decision Making. View this article in WRRO
- An exploration of the non‐iterative time trade‐off method to value health states. Health Economics, 27(8), 1247-1263. View this article in WRRO
- How Robust Are Value Judgments of Health Inequality Aversion? Testing for Framing and Cognitive Effects. Medical Decision Making, 37(6), 635-646. View this article in WRRO
- Valuing health at the end of life: A stated preference discrete choice experiment. Social Science & Medicine, 124, 48-56. View this article in WRRO
- View this article in WRRO Is more health always better for society? Exploring public preferences that violate monotonicity.. Theory and Decision.
- A UNIFORM TIME TRADE OFF METHOD FOR STATES BETTER AND WORSE THAN DEAD: FEASIBILITY STUDY OF THE 'LEAD TIME' APPROACH. HEALTH ECON, 20(3), 348-361.
- Equality of what in health? Distinguishing between outcome egalitarianism and gain egalitarianism.. Health Econ, 18(2), 147-159.
- The social welfare function and individual responsibility: Some theoretical issues and empirical evidence. J HEALTH ECON, 28(1), 210-220.
- Public healthcare resource allocation and the Rule of Rescue. J MED ETHICS, 34(7). View this article in WRRO
- A "fair innings" between the sexes: are men being treated inequitably?. Soc Sci Med, 60(2), 277-286.
- Exploring social welfare functions and violation of monotonicity: an example from inequalities in health. J HEALTH ECON, 23(2), 313-329.
- Measuring people's preferences regarding ageism in health: some methodological issues and some fresh evidence.. Soc Sci Med, 57(4), 687-696.
- QALYs and ageism: philosophical theories and age weighting.. Health Econ, 9(1), 57-68.
- Research group
I am interested in supervising PhD students in normative issues related to resource allocation and priority setting in health and wellbeing.
- Teaching interests
- health economics for economists
- valuation of health states
- normative health economics
I teach health economics, which is about the application of economic concepts to matters of health, healthcare, and healthcare insurance. But, to what extent can we apply economics to matters of life and limb? Some think that whenever somebody’s life is at stake, it is unethical to think of costs, and thus “health” and “economics” sit very awkwardly with each other. However, if we ignore opportunity costs, then efficiency would be compromised and we would achieve less health overall. At the same time, most of us want a health care system that is not just efficient, but also equitable. Health economics enables the analysis of health care systems in the light of efficiency, equity, or both.
In health economics, there are numerous issues that involve value judgements, with no easy right answers. Should we use monetary valuation of health to analyse the efficiency of different drugs? Should health policy aim to maximise health or to maximise more general wellbeing? Should we forego any efficiency in order to improve equity in health outcomes? My approach to teaching is to encourage students to take an informed view on such issues, and then to defend these views (which may not agree with mine!).
- Professional activities
- Co-Director for Centre for Wellbeing in Public Policy
- Course Director for MSc Economics and Health Economics
- Co-Chair of the Athena SWAN Self-Assessment Group (ScHARR)